Omega Healthcare Investors, Inc. (NYSE:OHI ) Q4 2024 Earnings Conference Call February 6, 2025 10:00 AM ET Company Participants Michele Reber - IR Taylor Pickett - CEO Bob Stephenson - CFO Megan Krull - SVP, Operations Matthew Gourmand - President Vikas Gupta - Chief Investment Office Conference Call Participants Jonathan Hughes - Raymond James Michael Griffin - Citi John Kilichowski - Wells Fargo Juan Sanabria - BMO Capital Markets Nick Yulico - Scotia Bank Farrell Granath - Bank of America Merrill Lynch Michael Carroll - RBC Capital Markets Alec Feygin - Baird Emily Meckler - Green Street Vikram Malhotra - Mizuho Operator Thank you for standing by. My name is Kate and I will be your conference operator today.
Although the revenue and EPS for Omega Healthcare Investors (OHI) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Omega Healthcare Investors (OHI) came out with quarterly funds from operations (FFO) of $0.74 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to FFO of $0.68 per share a year ago.
Omega Healthcare Investors is a leading healthcare REIT focused on skilled nursing facilities, benefiting from aging U.S. population trends and improved pay-out metrics. Despite Covid-related setbacks, OHI has maintained a $0.67 per share quarterly dividend, offering a well-covered 7% yield and moderate valuation. OHI's adjusted funds from operations have grown, allowing potential portfolio expansion and a favorable risk/reward relationship at a $36 price point.
Omega Healthcare Investors is a leading triple-net lease REIT specializing in skilled nursing facilities, offering a 7.2% yield supported by improving fundamentals. OHI has shown resilience, evidenced by strong Q3 results, revenue growth, and a fully covered dividend, making it an attractive buy. Strategic investments in senior housing and operator recoveries position OHI to capitalize on growing demand from an aging population.
The benchmark S&P 500 index keeps reaching new highs, but not all of its components have participated in the rally. Royalty Pharma (RPRX 0.04%), W.P.
OHI produced a strong Q3 beating on the top and bottom line as they came in ahead of the consensus estimate of $0.38 EPS with $0.42. OHI continued to make progress in Q3 having completed $440 million in new investments which included real estate acquisitions. I am downgrading my outlook to neutral as shares have run more than 30% in 2024 and look fairly valued compared to OHI's peers.
The past couple of years have been terrific for stocks, with the benchmark S&P 500 index up a whopping 57.1% since the end of 2022. However, after the index's two-year bull run, it's getting harder to find quality dividend stocks that offer satisfying yields.
Omega Healthcare Investors has shown significant improvements, with FFO and revenue beating estimates, and strong growth in tenant payments and new investments in 2024. The REIT's payout ratio has decreased but remains high at 96%; management expects it to fall below 90% in upcoming quarters. OHI's valuation has increased, with a forward P/AFFO multiple of 14.07x, still below the sector median, offering potential upside.
Omega Healthcare Investors, Inc. (NYSE:OHI ) Q3 2024 Earnings Conference Call October 31, 2024 10:00 AM ET Company Participants Michele Reber - IR Taylor Pickett - CEO Dan Booth - COO Bob Stephenson - CFO Megan Krull - SVP, Operations Conference Call Participants Jonathan Hughes - Raymond James Michael Griffin - Citi John Kilichowski - Wells Fargo John Pawlowski - Green Street Nick Yulico - Scotia Bank Juan Sanabria - BMO Capital Markets Justin Haasbeek - RBC Capital Markets Alec Feygin - Baird Joe Dickstein - Jefferies Operator Thank you for standing by. My name is Jill and I'll be a conference operator today.
While the top- and bottom-line numbers for Omega Healthcare Investors (OHI) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Omega Healthcare Investors (OHI) came out with quarterly funds from operations (FFO) of $0.74 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to FFO of $0.71 per share a year ago.